Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Neuropharmacology. 2018 Mar 1;142:240–250. doi: 10.1016/j.neuropharm.2018.02.033

Figure 1.

Figure 1

Chemical structures of 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine (DOI); 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine (2C-C), and its N-methoxybenzylated derivative 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe); and 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C-I), and its N-methoxybenzylated derivative 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe).

HHS Vulnerability Disclosure